Procainamide Hydrochloride Injection, Solution
Product Images NDC 0409-1902

6 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Procainamide Hydrochloride (NDC 0409-1902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Procainamide Hydrochloride (Procainamide 01)

Structural Formula Procainamide Hydrochloride (Procainamide 01)
Chemical structure of Procainamide Hydrochloride showing the molecular arrangement with amine group, benzene ring, amide linkage, and diethylaminoethyl side chain bound to hydrochloride.*
FDA Label Image

Logo (Procainamide 02)

FDA Label Image

Principal Display Panel (10 mL Vial Label)

Principal Display Panel (10 mL Vial Label)
Procainamide Hydrochloride Injection, USP 100 mg/mL in a 10 mL multiple-dose vial label. The label states the total amount as 1 gram per 10 mL, includes preservative methylparaben and sodium metabisulfite, and notes it may contain HCl and NaOH for pH adjustment. It is distributed by Hospira, Inc., Lake Forest, IL.*
FDA Label Image

Principal Display Panel (10 mL Vial Carton)

Principal Display Panel (10 mL Vial Carton)
The image shows the flat label for Procainamide Hydrochloride Injection, USP by Hospira, Inc. It is a multiple-dose 10 mL vial containing 1 gram per 10 mL total (100 mg/mL) procainamide hydrochloride. The label includes dosage warnings, storage instructions, and a barcode, with lot and expiration date placeholders visible.*
FDA Label Image

Principal Display Panel (2 mL Vial Label)

Principal Display Panel (2 mL Vial Label)
Label for Procainamide Hydrochloride Injection, USP, 500 mg/mL (1 gram/2 mL), multiple-dose vial. The label includes NDC 0409-1903-41, Rx only, and is distributed by Hospira, Inc., Lake Forest, IL. The vial volume is 2 mL with a dosage strength of 500 mg/mL.*
FDA Label Image

Principal Display Panel (2 mL Vial Carton)

Principal Display Panel (2 mL Vial Carton)
Procainamide Hydrochloride Injection USP 1 gram/2 mL total (500 mg/mL) multiple-dose vial carton. The label states the drug is for injection by intramuscular or intravenous routes. It is distributed by Hospira, Inc. and includes warnings about preservatives and storage instructions. The carton features lot and expiration date placeholders, a barcode, and dosage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.